FierceBiotech21d
Roche nets clearances for sexually transmitted infection tests at the point of care
Roche has obtained U.S. government green lights allowing its point-of-care testing system to be used to screen for multiple sexually transmitted infections from a single sample. The company’s ...
BioWorld23d
Roche receives FDA approval for STI point-of-care tests
Roche AG secured U.S. FDA 510(k) clearance for its cobas liat sexually transmitted infection (STI) multiplex assay panels. The tests, which also received a Clinical Laboratory Improvement Amendments ...
Yahoo Finance21d
Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care
Basel, 22 January 2025 - Roche (SIX: RO, ROG ... “Rapid molecular point-of-care testing can revolutionise the clinical management of STIs in decentralised and community-based healthcare settings ...